BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17669511)

  • 1. Different patterns of activation markers expression and CD4+ T-cell responses to ex vivo stimulation in patients with clinically quiescent multiple sclerosis (MS).
    Kosmaczewska A; Bilinska M; Ciszak L; Noga L; Pawlak E; Szteblich A; Podemski R; Frydecka I
    J Neuroimmunol; 2007 Sep; 189(1-2):137-46. PubMed ID: 17669511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40L, CD28, and CTLA-4 expression on CD4+ T cells in kidney graft recipients: a relationship with post-transplantation clinical course.
    Kosmaczewska A; Magott-Procelewska M; Frydecka I; Ciszak L; Bocko D; Szteblich A; Kusnierczyk P; Patrzalek D; Szyber P; Klinger M
    Transpl Immunol; 2006 Jun; 16(1):32-40. PubMed ID: 16701174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sex hormones on costimulatory molecule expression in multiple sclerosis.
    Pelfrey CM; Moldovan IR; Cotleur AC; Zamor N; Rudick RA
    J Neuroimmunol; 2005 Oct; 167(1-2):190-203. PubMed ID: 16046001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin treatment of chronic renal failure patients normalizes altered phenotype and proliferation of CD4-positive T lymphocytes.
    Lisowska KA; Debska-Slizien A; Radzka M; Witkowski JM; Rutkowski B; Bryl E
    Artif Organs; 2010 Mar; 34(3):E77-84. PubMed ID: 20447038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced CD40L expression on ex vivo activated CD4+ T-lymphocytes from patients with excellent renal allograft function measured with a rapid whole blood flow cytometry procedure.
    Lederer SR; Friedrich N; Gruber R; Landgraf R; Toepfer M; Sitter T
    Int Arch Allergy Immunol; 2004 Mar; 133(3):276-84. PubMed ID: 14976397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoids inhibit CD40 ligand expression of peripheral CD4+ lymphocytes.
    Bischof F; Melms A
    Cell Immunol; 1998 Jul; 187(1):38-44. PubMed ID: 9682002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prolactin as a novel immunomodulator on the expression of co-stimulatory molecules and cytokine secretions on T and B human lymphocytes.
    Chavez-Rueda K; Hérnández J; Zenteno E; Leaños-Miranda A; Legorreta-Haquet MV; Blanco-Favela F
    Clin Immunol; 2005 Aug; 116(2):182-91. PubMed ID: 15993365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PD-1 polymorphism is associated with disease progression in multiple sclerosis.
    Kroner A; Mehling M; Hemmer B; Rieckmann P; Toyka KV; Mäurer M; Wiendl H
    Ann Neurol; 2005 Jul; 58(1):50-7. PubMed ID: 15912506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L; Conti L; Clerico M; Boselli D; Contessa G; Ripellino P; Ferrero B; Eid P; Novelli F
    Ann Neurol; 2009 May; 65(5):499-509. PubMed ID: 19475668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis.
    Miyazaki Y; Iwabuchi K; Kikuchi S; Fukazawa T; Niino M; Hirotani M; Sasaki H; Onoé K
    Mult Scler; 2008 Sep; 14(8):1044-55. PubMed ID: 18573819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-beta treatment.
    Jensen J; Langkilde AR; Frederiksen JL; Sellebjerg F
    J Neuroimmunol; 2006 Oct; 179(1-2):163-72. PubMed ID: 16919783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis.
    Julià E; Montalban X; Al-Zayat H; Issazadeh-Navikas S; Goertsches R; Martin R; Comabella M
    J Neuroimmunol; 2006 Nov; 180(1-2):147-58. PubMed ID: 16899302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related increase in the frequency of CD4(+) T cells that produce interferon-gamma in response to staphylococcal enterotoxin B during childhood.
    Hanna-Wakim R; Yasukawa LL; Sung P; Fang M; Sullivan B; Rinki M; DeHovitz R; Arvin AM; Gans HA
    J Infect Dis; 2009 Dec; 200(12):1921-7. PubMed ID: 19909079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis.
    Okuda Y; Apatoff BR; Posnett DN
    J Neuroimmunol; 2006 Feb; 171(1-2):163-70. PubMed ID: 16290072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CD40 ligand in patients with acute anterior uveitis.
    Øgard C; Sørensen TL; Krogh E
    Acta Ophthalmol Scand; 2005 Jun; 83(3):370-3. PubMed ID: 15948793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential susceptibility to apoptosis of CD4+T cells expressing CCR5 and CXCR3 in patients with MS.
    Julià E; Edo MC; Horga A; Montalban X; Comabella M
    Clin Immunol; 2009 Dec; 133(3):364-74. PubMed ID: 19740704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD69 on T-cell subsets in HIV-1 disease.
    Pitsios C; Dimitrakopoulou A; Tsalimalma K; Kordossis T; Choremi-Papadopoulou H
    Scand J Clin Lab Invest; 2008; 68(3):233-41. PubMed ID: 17917998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factor-alpha-secreting T lymphocytes in multiple sclerosis patients.
    Strunk T; Bubel S; Mascher B; Schlenke P; Kirchner H; Wandinger KP
    Ann Neurol; 2000 Feb; 47(2):269-73. PubMed ID: 10665504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of CD4+TNF{alpha}+IL-2-T cells in cerebrospinal fluid of multiple sclerosis patients.
    Shi N; Kawano Y; Matsuoka T; Mei F; Ishizu T; Ohyagi Y; Kira J
    Mult Scler; 2009 Jan; 15(1):120-3. PubMed ID: 18755820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of adhesion molecules on peripheral lymphocytes predicts future lesion development in MS.
    Eikelenboom MJ; Killestein J; Izeboud T; Kalkers NF; Baars PA; van Lier RA; Barkhof F; Uitdehaag BM; Polman CH
    J Neuroimmunol; 2005 Jan; 158(1-2):222-30. PubMed ID: 15589057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.